2020 In Review: Despite Pandemic, The US FDA Issued Just 20% Fewer Drug GMP Warning Letters

2021 warning letter rate could decline further

 
• By Joanne S. Eglovitch
warning sign
Majority Of FDA's GMP Warning Letters Hit Domestic Firms Last Year

More from Manufacturing

More from Compliance